We evaluated the natural course of congenital aortic valvular stenosis (AVS) and factors affecting AVS progression during long-term follow-up with echocardiography. Medical records of 388 patients with AVS were reviewed; patients with concomitant lesions other than aortic regurgitation (AR) were excluded. Trivial AVS was defined as a transvalvular Doppler peak systolic instantaneous gradient of < 25 mmHg; mild stenosis, 25-49 mmHg; moderate stenosis, 50-75 mmHg; and severe stenosis, > 75 mmHg. Median age of the patients was 3 years (range 0 day to 21 years), and 287 (74%) were male. A total of 355 patients were followed with medical treatment alone for a median of 4.6 years (range 1 month to 20.6 years), and the degree of AVS increased in 75 (21%) patients. The risk of AVS progression was higher when AVS was diagnosed in neonates (OR 4.29, CI 1.81-10.18, p = 0.001) and infants (OR 3.79, CI 2.21-6.49, p = 0.001). After the infancy period, bicuspid valve morphology increased AVS progression risk (OR 2.4, CI 1.2-4.6, p = 0.034). Patients with moderate AVS were more likely to have AVS progression (OR 2.59, CI 1.3-5.1, p = 0.006). Bicuspid valve morphology increased risk of AR development/progression (OR 1.77, CI 1.1-2.7, p = 0.017). The patients with mild and moderate AVS were more likely to have AR development/progression (p = 0.001). The risk of AR development/progression was higher in patients with AVS progression (OR 2.25, CI 1.33-3.81, p = 0.002). Newborn babies and infants should be followed more frequently than older patients according to disease severity. Bicuspid aortic valve morphology and moderate stenosis are risk factors for the progression of AVS and AR.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00246-018-1928-2DOI Listing

Publication Analysis

Top Keywords

avs progression
20
avs
13
valve morphology
12
patients
9
congenital aortic
8
aortic valvular
8
valvular stenosis
8
patients avs
8
bicuspid valve
8
morphology increased
8

Similar Publications

Background: Aortic valve stenosis (AVS) is a progressive disease characterized by fibrosis, inflammation, calcification, and stiffening of the aortic valve leaflets, leading to disrupted blood flow. If untreated, AVS can progress to heart failure and death within 2 to 5 years. Uncovering the molecular mechanisms behind AVS is key for developing effective noninvasive therapies.

View Article and Find Full Text PDF

Anelloviruses and Cancer.

J Infect Dis

December 2024

San Diego Supercomputer Center, University of California, San Diego, California, USA.

Anelloviruses are among the most prevalent viruses within the human virome, detected in over 90% of healthy individuals. Despite their ubiquity, the role of anelloviruses in human health remains elusive. This review examines the potential associations of anelloviruses torque teno virus (TTV), torque teno midi virus (TTMDV), and torque teno mini virus (TTMV) with various cancers, highlighting the mixed conclusions from current epidemiological studies.

View Article and Find Full Text PDF

Aortic valve sclerosis is not a benign finding but progressive disease associated with poor cardiovascular outcomes.

J Cardiovasc Imaging

November 2024

Division of Cardiology, Department of Internal Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon, Republic of Korea.

Background: Aortic valve sclerosis (AVS) shares risk factors with atherosclerosis. However, the relationship between AVS progression with cardiovascular (CV) risk has not been researched. This study investigates CV outcomes according to progression of AVS.

View Article and Find Full Text PDF

As aortic valve stenosis (AVS) progresses, the valve tissue also stiffens. This increase in tissue stiffness causes the valvular interstitial cells (VICs) to transform into myofibroblasts in response. VIC-to-myofibroblast differentiation is critically involved in the development of AVS.

View Article and Find Full Text PDF

Promotes Osteogenic Differentiation and Calcification of Valvular Interstitial Cells by Targeting in Calcific Aortic Valve Disease.

Iran J Public Health

October 2024

Department of Cardiothoracic Surgery, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, Yancheng, Jiangsu 224000, China.

Article Synopsis
  • Calcific aortic valve disease (CAVD) is a significant health issue primarily affecting the elderly, with unclear factors driving valve mineralization despite extensive research.
  • This study examined tissues from 15 patients to investigate how specific microRNAs (mirnas) and their targets contribute to CAVD progression, utilizing methods like RT-qPCR and western blotting for analysis.
  • Results indicated increased levels of certain factors associated with calcified aortic valves, suggesting that these factors promote vascular interstitial cell (VIC) calcification and differentiation, potentially identifying new therapeutic targets for treating CAVD.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!